Physician profile
Urmi Das
NPI 1235516022
$1,469.43
in general payments reported to CMS, 2019-2025
15 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58.95 · 2021: $109 · 2022: $227 · 2023: $362 · 2024: $257 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.98 | 2021-2024 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $284.99 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $189.77 | 2022-2025 | |
| Lilly USA, LLC | $165.65 | 2020-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $164.92 | 2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $85.50 | 2020-2025 | Shingrix, Fluarix Quadrivalent, Arexvy |
| Merck Sharp & Dohme LLC | $66.01 | 2022-2023 | Belsomra, Steglujan, Steglatro |
| Amgen INC. | $49.39 | 2025 | Otezla, Repatha, Prolia |
| Exact Sciences Corporation | $47.85 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $27.26 | 2025 | Injectafer |
| Axsome Therapeutics, INC. | $26.42 | 2023 | Auvelity |
| Hologic Sales and Service, LLC | $23.16 | 2025 | Aptima |
| Abbott Laboratories | $19.43 | 2025 | Freestyle Libre 3 |
| Mayne Pharma Commercial LLC | $16.92 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Urmi Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.